KPC Pharmaceuticals Overview
- Founded
- 1951

- Status
- Public
- Employees
- 1,275

- Stock Symbol
- 600422

- Investments
- 8
- Share Price
- $1.78
- (As of Thursday Closing)
KPC Pharmaceuticals General Information
Description
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Contact Information
Website
www.kpc.com.cn
Formerly Known As
Kunming Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Primary Office
- No. 166 Keyi Road
- State New and High Technology Development Zone
- Kunming, Yunnan 650106
- China
+86 0871 0000 0000
KPC Pharmaceuticals Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.78 | $1.79 | $1.26 - $2.31 | $1.35B | 758M | 23.5M | $0.09 |
KPC Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 1,332,642 | 1,253,949 | 913,680 | 1,079,390 |
Revenue | 1,357,584 | 1,278,214 | 1,117,025 | 1,175,164 |
EBITDA | 88,590 | 130,589 | 103,181 | 101,716 |
Net Income | 66,501 | 78,622 | 66,129 | 65,750 |
Total Assets | 1,421,065 | 1,395,165 | 1,257,042 | 1,062,619 |
Total Debt | 146,794 | 129,900 | 125,241 | 86,687 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
KPC Pharmaceuticals Patents
KPC Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-2292242-B1 | A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof | Active | 22-May-2008 | 00000000000 | |
EP-2292242-A1 | A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof | Granted | 22-May-2008 | 00000000000 | |
EP-2292242-A4 | A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof | Granted | 22-May-2008 | 00000000000 | |
EP-2292241-A4 | A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof | Withdrawn | 22-May-2008 | 00000000000 | |
EP-2292241-A1 | A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof | Withdrawn | 22-May-2008 | A61K31/7048 |
KPC Pharmaceuticals Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Zhong Xianggang | President | ||
Wang Shaoquan | Chief Financial Officer | ||
Xu Chaoneng | Vice President & Secretary of the Board |
KPC Pharmaceuticals Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
000 0000000 | KPC Pharmaceuticals | Vice Chairman of the Board | 000 0000 |
KPC Pharmaceuticals Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialKPC Pharmaceuticals Investments & Acquisitions (8)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000000 | 29-Oct-2020 | 00000 0000 | 000.00 | Biotechnology | |
00000000 | 29-Jul-2016 | 00000 0000 | 0000 | Biotechnology | |
0000 00000000 | 08-Mar-2016 | 00000 0000 | 000.00 | Drug Delivery | |
000000000000 | 27-Jan-2016 | 00000 0000 | 00.000 | Application Software | |
E-Young | 28-Dec-2015 | Seed Round | Educational Software |
KPC Pharmaceuticals Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
00000 0000 0000000 | Distributors/Wholesale | Changsha, China | 0000 |
KPC Pharmaceuticals Exits (2)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000 000000000000 | 08-Mar-2016 | 00000 00000 00 | 000.00 | Completed |
|
Rani Therapeutics | 16-Jul-2015 | Later Stage VC | 000.00 | Completed |
|